CA-CEPTON-TECHNOLOGIES
A state-of-the art electronic tolling system that utilizes high-performance lidar sensors from Cepton and a cutting-edge vehicle identification solution from Red Fox ID is expected to be deployed on a major highway turnpike crossing multiple states in the United States, thereby promising fast, highly accurate, barrier-free, real-time tolling to enable smooth traffic flows. This marks the maturing of the deep partnership between Cepton and Red Fox ID in bringing innovative, automated tolling solutions to major customers across North America, EMEA and Asia.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210302005524/en/
Based on an extended collaboration with leading lidar solution provider Cepton, Red Fox ID – a leading designer and developer of vehicle identification and classification solutions - has developed a multi-lane, free flow tolling system called Quantum , which is able to accurately detect, track and classify vehicles of any size or type at highway speeds. Quantum uses Cepton’s Micro Motion Technology (MMT® ) based Sora™-P60 or Sora™-P90 lidar sensors for high-resolution vehicle profiling, to enable integrators and road operators to achieve highly accurate customer billing in real time, with free flow, barrier-free tolling.
For tolls to be charged correctly based on vehicle class, traditional tolling systems often use tollbooths for manual processing or depend on vehicle speed reduction infrastructure to allow for time to capture vehicle information. That can cause congestion, increased emissions and frustration amongst customers. More advanced systems that aim to enable faster tolling, however, are often subject to significant errors, such as missed vehicles or wrong vehicle classification, due to known limitations of the sensors currently being used, such as cameras and weight-based ground sensors. Vehicle classification errors can have significant operating cost consequences for tolling operators while leakage leads to lower revenues. With tollways processing tens of millions of vehicles a year, the cumulative impact of inaccuracies and errors creates significant administrative costs, losses and customer dissatisfaction.
Red Fox ID’s Quantum solution addresses such challenges by adding an extra layer of accuracy to the tolling system by integrating Cepton’s unique lidar technology. A gantry-mounted system using Quantum is therefore able to accurately detect and track vehicles, even as they switch lanes. The lidar-enabled Quantum solution captures and extracts high quality information, such as vehicle velocity, size and class. All of that information is used as input to a separate billing system to compute and apply the appropriate tolling charge. Quantum can also direct camera-based systems on the gantry to capture a vehicle’s front and rear plates in the event that a transponder cannot be detected. Through these innovations, Quantum has demonstrated a vehicle detection accuracy in all traffic conditions of 99.96%, an axle classification accuracy in all traffic conditions of 99.9% and a vehicle length accuracy of +/-5%. This world-class performance is enabled by Cepton’s innovative Sora-P sensor family which has been tested and proven during extended trials, including in various weather and light conditions.
The recently released Sora-P90 lidar features an industry-leading 380 Hz frame rate to deliver 1140 line scans per second, providing high-fidelity profiling of vehicles passing at highway speeds . Powered by Cepton’s patented, rotation-free, frictionless and mirrorless MMT® , the Sora-P90 is rugged, reliable and scalable, making it ideally suited for automated tolling applications. In addition, with its 90° horizontal field of view, the lidar can be set up using one gantry instead of requiring two separate sensors and gantries, making overall deployment more cost effective for tolling system integrators.
With their unparalleled experienced in building innovative tolling solutions, and deep understanding of the industry trend away from ground loop-based tolling systems towards next-generation gantry-based overhead systems powered by advanced sensor technologies, Red Fox ID has been working with Cepton on multiple trials and proof of concept projects across the globe since 2019. This has allowed both partners to expand the application of advanced lidar intelligence for high accuracy tolling on highways and roadways in a growing list of countries, across North America, EMEA and Asia.
Steve Bird, CEO of Red Fox ID, said: “Our industry’s drive for overhead tolling solutions has failed to materialize in the mainstream due, primarily, to a lack of sensors capable of achieving the high levels of accuracy required for a modern tolling product. The technical innovations enabled by Cepton offers us new design options. Improvements in the resolution of the data, the ability to deal with the full range of weather-related conditions, and the development of a sensor with an in-service lifespan suitable for tolling make it possible, for the first time, for us to develop an accurate, overhead free flow system. Our partnership with Cepton will be a game-changer in revolutionizing the tolling market.”
Dr. Jun Pei, CEO of Cepton, added: “It is very clear that lidar’s uses extend far beyond just serving as the ‘eyes’ of autonomous vehicles. Our lidar technology has a huge part to play in making our transport infrastructure smarter, safer, greener and more efficient, as we can see here following Quantum’s highly successful real-world testing. The key to success for toll operators and providers is minimal error and maximum yield, and we are excited to be partnering with Red Fox ID to help our mutual customers achieve this goal with our market-leading lidar technology. We look forward to working with them to expand our partnership worldwide.”
About Cepton Technologies, Inc.
Cepton provides state-of-the-art, intelligent, lidar-based solutions for a range of markets such as automotive (ADAS/AV), smart cities , smart spaces and smart industrial applications. Cepton’s patented MMT®-based lidar technology enables reliable, scalable and cost-effective solutions that deliver long range, high resolution 3D perception for smart applications.
Founded in 2016 and led by industry veterans with over two decades of collective experience across a wide range of advanced lidar and imaging technologies, Cepton is focused on the mass market commercialization of high performance, high quality lidar solutions. Cepton is headquartered in San Jose, California, USA, with a presence in Germany, Canada, Japan and India, to serve a fast-growing global customer base. For more information, visit www.cepton.com and follow us on Twitter and LinkedIn .
About Red Fox ID Limited
Red Fox ID is a technology provider, primarily for the global tolling market and also for the broader ITS markets.
A company with over 3 decades of proven experience in the delivery of innovative, forward looking and industry leading solutions for the world of all weather, multi-lane, free-flow automatic vehicle detection and classification (AVDC). System integrators, toll authorities and road operators select Red Fox ID for their experience in advance sensor integration and expertise in road side tolling systems, from the software to the road side Red Fox ID has domain experts that ensure timely delivery of the industries most accurate AVDC system.
For more information visit www.redfoxid.co.uk or contact us at sales@redfoxid.co.uk or call +44 7866845819.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210302005524/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
CoMotion GLOBAL 2025 Launches in Riyadh: Global Mobility Leaders Unite in Saudi Capital to Chart Urban Future7.12.2025 13:00:00 CET | Press release
Summit debuts Mayors in Motion initiative and CoMotion Urban Visionary Distinction as Riyadh showcases its rise as global mobility testbed Riyadh is rapidly becoming one of the world's most ambitious urban mobility laboratories, where next-generation technologies move from blueprint to real-world deployment on city streets at unprecedented scale. CoMotion GLOBAL 2025, the world's most influential gathering of urban mobility leaders, opens today in Riyadh for a three-day summit bringing together innovators from Africa, Asia, Europe, the Americas, and the Middle East. Running December 7-9, the event will explore how electrification, autonomy, AI-enabled transport, and giga-project urbanism are reshaping cities worldwide. The summit will spotlight everything from high-performance EVs and breakthrough autonomous fleets to emerging-market transport solutions and new mobility models, demonstrating how the Kingdom is opening new pathways for global mobility leadership. Strategic Partnerships
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release
Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release
52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society
Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 13:01:00 CET | Press release
- Data from pivotal studies of CASGEVY in children ages 5-11 years with severe sickle cell disease or transfusion-dependent beta thalassemia demonstrates the transformative potential of the therapy in younger patients -- Efficacy and safety data in children 5-11 years are consistent with the durable and positive benefit/risk profile established from clinical studies in patients 12 years of age and older -- Vertex expects to initiate global regulatory submissions for CASGEVY in children 5-11 years in 1H 2026 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and
Leading Global Scientists Gather at Tengchong Scientists Forum to Explore Innovative Pathways in Frontier Technologies6.12.2025 12:31:00 CET | Press release
The 2025 Tengchong Scientists Forum opened on Saturday in southwest China’s Yunnan Province, convening leading scientists and academic figures to examine innovation across frontier fields including artificial intelligence, biodiversity and quantum technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205499197/en/ Opening ceremony of Tengchong Scientists Forum on 6th December, 2025 Notable participants include Nobel Physics laureate Konstantin Novoselov, Fields Medalist Efim Zelmanov and Turing Award winner Andrew Chi-Chih Yao, who join 127 academicians, 77 university presidents from China and abroad, over 400 scholars and more than 600 entrepreneurs and financiers. The gathering aims to deepen collaboration between cutting-edge research and industrial development. Under the theme “Science · AI changing the World,” the forum features ten sub-forums, academic sessions and thematic events supporting major cooperation p
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
